Actively Recruiting
Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-05-11
2419
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
Sponsors
N
National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor
M
Medstar Health Research Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
We are studying virologic and/or immunologic parameters of HIV infection and other infectious or non-infectious immune deficiency diseases in order to better understand the pathogenesis of HIV. Because of the lack of an adequate animal model it is generally necessary to utilize human peripheral blood cells for studying aspects of either in vivo or in vitro HIV infection. We wish to be able to continue to elucidate many pathogenic aspects of HIV infection in relation to other infectious or non-infectious immune regulation and dysregulation using human peripheral blood mononuclear cells as a model.
CONDITIONS
Official Title
Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older.
- Adequate venous access.
- Blood pressure less than or equal to 180/100 and pulse rate between 50 and 100, or a lower pulse rate if normal.
- Adequate blood counts: hemoglobin greater than or equal to 9.0 g/dL and platelets greater than or equal to 50,000.
- Willing and able to provide written informed consent, comply with study requirements and clinic policies.
- Willing to allow blood samples to be used for future HIV pathogenesis studies and undergo hepatitis screening.
You will not qualify if you...
- Pregnant and/or breastfeeding females.
- Active substance abuse or history of substance abuse that may interfere with study compliance or safety.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010
Completed
2
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
Research Team
C
Catherine A Seamon, R.N.
CONTACT
S
Susan L Moir, Ph.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here